Join us on May 19, 2026 for the third annual exclusive gathering of senior-level investors, corporate executives, entrepreneurs, and startup leaders from the biotech, tech bio, biomedical research, drug discovery, and healthcare sectors.
2025 Summary
Bio-IT World Venture, Innovation & Partnering
Uniting Investors and Leaders: Advancing Innovation
Join 200+ C-Suite industry stakeholders at the Bio-IT World Venture, Innovation & Partnering Conference on April 3, 2025, in Boston, the US’s top biotech hub. This exclusive single-day event, featuring a highly select group, is part of the renowned Bio-IT World Conference & Expo. This meeting brings together venture capitalists, private equity professionals, bank investors, government partners, start-ups, and industry leaders focusing on investment trends, challenges, and opportunities in biomedical research, drug discovery, and healthcare technology. Additionally, your registration includes access to the Bio-IT World exhibit hall with 150+ emerging businesses, 11 scientific tracks, and networking receptions.
2025 Co-Chairs
Luba Greenwood
Managing Partner
Dana-Farber Cancer Institute, Binney Street Capital
John Keilty
Venture Partner
Third Rock Ventures
Bill Mayo
Senior Vice President Research, IT
Bristol Myers Squibb
2025 Featured Speakers
Barry Canton
Co-Founder and CTO, Ginkgo Bioworks
Michelle Chen, CEO
Insilico Medicine
Brett Cook
Partner, F-Prime
Cris Deluca
Partner, Sanofi Ventures
Andrew Hedin
Partner, Bessemer Venture Partners
Milind Kamkolkar
Venture Partner, RA Capital
Derek Lowe, PhD
Director, Chemical Biology & Therapeutics, Novartis BioMedical Research
Scott Megaffin
CEO, Adiso Therapeutics
Rana Lonnen
General Partner, Science Capital
Kimberly Nearing
Venture Partner, BVCF Management
Stephanie Oestreich
Managing Director, Myeloma Investment Fund
Claire Smith
Partner, Springtide
Jo Viney
CEO, President, Founder, Seismic Therapeutic
Anna Marie Wagner
Independent Board, Member & Advisor
Below is a partial list of perennials players at this year’s event
Who Should Attend
INVESTMENT FIRMS:
START-UPS and GROWTH COMPANIES:
CORPORATIONS:
